Table 1

Demographic and clinical characteristics of prostate cancer patients by tumor TMPRSS2-ERG gene fusion status.

TMPRSS2-ERG Gene Fusion Status

Characteristics

Not Scored1

Positive

Negative


n = 158

n = 76

n = 138

Age at diagnosis

Mean (SD)

61.2 (7.4)

59.3 (6.3)

59.9 (7.2)

Range

40 – 86

45 – 88

45 – 86

Gleason score (%)

2 - 7 (3+4)

138 (87.3)

63 (82.9)

115 (83.3)

7 (4+3) - 10

17 (10.8)

12 (15.8)

19 (13.8)

Missing

3 (1.9)

1 (1.3)

4 (2.9)

Stage (%)

Local

121 (76.6)

57 (75)

106 (76.8)

Regional

37 (23.4)

18 (23.7)

29 (21.0)

Distant

0 (0)

1 (1.3)

3 (2.2)

PSA value at diagnosis (ng/ml) (%)

0 – 9.9

92 (58.2)

52 (68.4)

91 (65.9)

≥ 10.0

41 (26.0)

16 (21.1)

29 (21.0)

Missing

25 (15.8)

8 (10.5)

18 (13.1)

Vital status (%)

Alive

129 (81.7)

65 (85.5)

119 (86.2)

Deceased

Prostate cancer-specific death

4 (2.5)

6 (7.9)

6 (4.4)

Other cause of death

25 (15.8)

5 (6.6)

12 (8.7)

Missing

0 (0)

0 (0)

1 (0.7)

Fusion Type

Translocation

-

38 (50)

-

Deletion

-

38 (50)

-

Fusion Number

Single

-

65 (85.5)

-

Multiple

-

11 (14.5)

-

Survival Time (years) (SD)

11.5 (2.6)

12.0 (2.6)

11.4 (3.1)


1Includes one equivocal case.

FitzGerald et al. BMC Cancer 2008 8:230   doi:10.1186/1471-2407-8-230

Open Data